Jenburkt Pharmaceuticals Ltd — Important, 04-09-2026: Company Update

The company has announced the proceedings of its 41st Annual General Meeting. This pivotal corporate event serves as a crucial platform for shareholders to actively engage in the company's governance and strategic oversight. Such meetings are fundamental for reviewing operational performance, understanding financial standing, and participating in key decisions. They are vital for fostering transparency and accountability, thereby strengthening investor confidence in the company's direction and overall business health.